Agency / Source: Bruker Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker BioSpin Group Introduces New Online Platform to Connect NMR Scientists and Advance NMR Research in Europe - Bruker Introduces Connexus: A NMR Capacity Sharing Cloud-based Platform for Collaboration between Scientists and Analytical Labs in Europe - Bruker.com
Bruker BioSpin Group Introduces New Online Platform to Connect NMR Scientists and Advance NMR Research in Europe

 

PRZOOM - /newswire/ - Zürich, Switzerland, 2022/01/26 - Bruker Introduces Connexus: A NMR Capacity Sharing Cloud-based Platform for Collaboration between Scientists and Analytical Labs in Europe - Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bruker BioSpin announces the introduction of Connexus® in Europe a cloud-based collaboration platform that connects nuclear magnetic resonance (NMR) scientists in need of analytical services and data evaluation expertise with NMR laboratories with available capabilities. By bringing the interested parties together, Connexus offers clients new access to previously inaccessible high-performance NMR technology and tools, while maximizing instrument productivity for laboratories providing analytical services.

By joining the Connexus Platform, academic and industry clients can now benefit from the latest technological advances and scientific instruments. Whether scientists are experiencing long queues at their own instruments or they lack the infrastructure, time, or expertise required for a particular project, they can now select and connect with a suitable provider based on analysis needs, location, and price. Connexus therefore alleviates the technological and capacity constraints that scientists may face and can help clients advance their research and analyses.

Participating laboratories, or service providers, can maximize their instrument uptime by providing analytical services to clients in need, thereby reducing the total cost of ownership (TCO) of an instrument. The additional income generated by joining Connexus provides an opportunity to optimize laboratory tools, processes and infrastructure. Finally, joining the Connexus network opens the door to developing a community of scientists, allowing members to collaborate, gain exposure to cutting-edge research, and advance scientific discoveries.

Connexus is the first commercially available platform of its kind offering a convenient and connected end-to-end workflow, from client requests to sample transport, uploading results and completing payments. Service providers and clients benefit from intra-platform interactions and seamless transactions. All communications and data are fully encrypted in the secure and user-friendly cloud-based software, which can be accessed from any browser without the need for time-consuming installations or updates.

Dr. Falko Busse, President of the Bruker BioSpin group, comments: “Bruker is widely regarded as a leader in analytical Magnetic Resonance instrumentation and tools, products and solutions. To complement our offerings to our customers, we continue to develop our digital capabilities to support the rapidly changing needs of the scientific community, especially in the post-COVID era. Connexus represents an important step in our vision of a digitally conscious total solution provider beyond instruments and a trusted business partner for our customers and the markets we serve.”

The Connexus rollout will initially start with a dedicated introductory program in European countries.

Connexus (bruker.com/connexus) is secured by the RFC 7519 authentication standard, meets the requirements of the FIPS 140-2 security standard and fully complies with the General Data Protection Regulation (GDPR).

About Bruker Corporation

Bruker (bruker.com) is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bruker BioSpin Group Introduces New Online Platform to Connect NMR Scientists and Advance NMR Research in Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Connexus | Bruker BioSpin
Contact: Thorsten Thiel, Ph.D. - Bruker.com 
+49(721) 5161 6500 thorsten.thiel[.]bruker.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Bruker Corporation / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Bruker’s Arxspan Business for Lab Informatics Expands Customer Capabilities by Joining Tetra Partner Network
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-line Monotherapy for Small Cell Lung Cancer
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-oncology Candidates from Marengo’s STAR Platform
SCHOTT Establishes Stand-alone Company for its Pharma Business to Promote Further Growth
Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific
BASF Expands World-scale Vitamin A Formulation Plant in Ludwigshafen
Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients
GenScript ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System
Ipsen Receives Positive Opinion in Europe for Dysport® in the Management of Urinary Incontinence in Adults

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  RightITnow, Inc.

Visit  JobsWare.com







 
  ©2022 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today